“…The use of propofol alone tends to increase the incidence of sedation-related serious adverse events, because it has dose-dependent response to upper airway collapse by inhibition of airway dilator muscle and of upper airway reflexes [ 2 , 5 , 8 ]. Therefore, concomitant administration of propofol with other sedative agents, such as midazolam, ketamine and dexmedetomidine, have been evaluated for pediatric procedural sedation [ 2 , 4 , 10 ]. Among various intravenous sedative agents for pediatric procedural sedation, propofol and midazolam have been preferred over others because of their high potency, short half-lives, and low potential of adverse effects [ 10 ].…”